Wealth Enhancement Advisory Services
IGMS

Wealth Enhancement Advisory Services’s IGM Biosciences IGMS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,584
Closed -$13.3K – 3434
2025
Q1 		$13.3K Buy
+11,584
New +$21.5K ﹤0.01% 2942

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wealth Enhancement Advisory Services's IGMS Position: Q2 2025 in Review

Wealth Enhancement Advisory Services sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 11,584 shares — an estimated $13.3K sold.

Wealth Enhancement Advisory Services first reported a position in IGMS in Q1 2025 and held it in 1 quarter. The position peaked at $13.3K in Q1 2025. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • Wealth Enhancement Advisory Services reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 11,584 IGM Biosciences shares in Q2 2025, an estimated $13.3K.
  • Wealth Enhancement Advisory Services first reported a position in IGM Biosciences in Q1 2025 and held it in 1 quarter.
  • Wealth Enhancement Advisory Services's IGM Biosciences position peaked at $13.3K in Q1 2025.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2025, filed 10 Jul 2025.